Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 44151-44200 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05699330
Subgenual Cingulate Deep Brain STIMulation for Apathetic Behavioral Variant FRONtotemporal Dementia
NA
Recruiting
6 participants
Started: Jan 12, 2023 · Completed: Jan 12, 2026
2 conditions
2 sponsors
1 location
NCT05649345
TR64 in Patients With Advanced Solid Tumors
PHASE1
Recruiting
19 participants
Started: Jan 12, 2023 · Completed: Dec 30, 2026
1 condition
1 sponsor
2 locations
NCT06696885
Mobile Applications for Exercise Adherence and Hand Function in Chronic Stroke.
NA
Recruiting
32 participants
Started: Jan 12, 2023 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT05745805
Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
N/A
Recruiting
600 participants
Started: Jan 12, 2023 · Completed: Sep 12, 2026
4 conditions
9 sponsors
1 location
NCT05278520
Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
N/A
Recruiting
110 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2028
2 conditions
3 sponsors
4 locations
NCT05526560
Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve
N/A
Recruiting
500 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2035
2 conditions
1 sponsor
37 locations
NCT04436978
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
PHASE4
Recruiting
2,000 participants
Started: Jan 11, 2023 · Completed: Dec 1, 2027
11 conditions
2 sponsors
20 locations
NCT06927349
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors.
PHASE1
Recruiting
70 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05633511
Changes of Soft Tissue Grafting: A Randomized Study
NA
Recruiting
50 participants
Started: Jan 11, 2023 · Completed: Dec 30, 2036
1 condition
1 sponsor
1 location
NCT06157008
Brain Network Analysis of Anesthesia Characteristics in Patients With pDoC Based on PSG
N/A
Recruiting
60 participants
Started: Jan 11, 2023 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT05386342
A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters
NA
Recruiting
112 participants
Started: Jan 11, 2023 · Completed: Jun 30, 2027
3 conditions
2 sponsors
3 locations
NCT05615974
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
PHASE1/PHASE2
Recruiting
139 participants
Started: Jan 11, 2023 · Completed: Jan 11, 2028
1 condition
1 sponsor
5 locations
NCT05773651
Rare Tumours in Children and Adolescents (STEP)
N/A
Recruiting
10,000 participants
Started: Jan 11, 2023 · Completed: Jan 31, 2055
1 condition
1 sponsor
1 location
NCT05727930
Variable Intensive Early Walking Post-Stroke - 2 (VIEWS-2)
NA
Recruiting
100 participants
Started: Jan 11, 2023 · Completed: Oct 15, 2028
1 condition
3 sponsors
1 location
NCT06838702
Structured Data Collection of Patients Undergoing Liver Transplantation and Evaluated for Bone Mineral Metabolism
N/A
Recruiting
150 participants
Started: Jan 11, 2023 · Completed: Jan 11, 2028
2 conditions
1 sponsor
1 location
NCT06094036
Physical Exercise as a Sustainability Tool in Men With Dysmetabolic Hypogonadism
NA
Recruiting
72 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2024
5 conditions
1 sponsor
1 location
NCT05555732
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
PHASE3
Recruiting
1,170 participants
Started: Jan 11, 2023 · Completed: Aug 1, 2027
1 condition
3 sponsors
252 locations
NCT05598151
Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
PHASE1
Recruiting
170 participants
Started: Jan 11, 2023 · Completed: Jun 30, 2028
1 condition
1 sponsor
10 locations
NCT05588154
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
N/A
Recruiting
1,000 participants
Started: Jan 11, 2023 · Completed: Dec 1, 2052
1 condition
1 sponsor
1 location
NCT06292741
Autonomic Involvement in Patient With Cognitive Decline
NA
Recruiting
120 participants
Started: Jan 11, 2023 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT05665504
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
N/A
Recruiting
250 participants
Started: Jan 11, 2023 · Completed: Feb 29, 2028
2 conditions
1 sponsor
1 location
NCT05337722
App for Pregnancy Smoking Cessation With Peer Support
NA
Recruiting
790 participants
Started: Jan 11, 2023 · Completed: Aug 31, 2025
2 conditions
4 sponsors
1 location
NCT05573126
Phase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
PHASE1/PHASE2
Recruiting
60 participants
Started: Jan 11, 2023 · Completed: Nov 30, 2026
3 conditions
1 sponsor
14 locations
NCT05997992
Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder
NA
Recruiting
100 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05527184
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
PHASE1
Recruiting
423 participants
Started: Jan 11, 2023 · Completed: Feb 28, 2027
5 conditions
1 sponsor
51 locations
NCT05676242
A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis
PHASE3
Recruiting
400 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
2 locations
NCT06465823
Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome
PHASE2
Recruiting
64 participants
Started: Jan 11, 2023 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT05501756
Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation
PHASE2
Recruiting
60 participants
Started: Jan 11, 2023 · Completed: Aug 31, 2028
1 condition
1 sponsor
1 location
NCT05709106
A Prospective Real World Study of Rimegepant in the Treatment of Migraine
N/A
Recruiting
100 participants
Started: Jan 11, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05982132
Weight Changes Among Martinican Prisoners
N/A
Recruiting
227 participants
Started: Jan 11, 2023 · Completed: Aug 31, 2025
2 conditions
1 sponsor
1 location
NCT05649982
Optimization of Guidance in a Digital Tool for Problematic Alcohol Use
NA
Recruiting
300 participants
Started: Jan 11, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05459233
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
NA
Recruiting
310 participants
Started: Jan 11, 2023 · Completed: Sep 1, 2029
3 conditions
1 sponsor
7 locations
NCT05746442
Ending Tobacco Use Through Interactive Tailored Messaging for Cambodian People Living With HIV/AIDS
NA
Recruiting
800 participants
Started: Jan 11, 2023 · Completed: Feb 28, 2027
2 conditions
4 sponsors
3 locations
NCT05663931
Diabetes Toolkit at Discharge
NA
Recruiting
120 participants
Started: Jan 10, 2023 · Completed: Sep 1, 2025
2 conditions
1 sponsor
1 location
NCT06333093
Duodenal tIssue ResEction aCquisiTion (DIRECT) Study
NA
Recruiting
30 participants
Started: Jan 10, 2023 · Completed: Jun 1, 2024
1 condition
1 sponsor
1 location
NCT05670847
Exogenous Ketone Esters for Drug Resistant Epilepsy
PHASE2/PHASE3
Recruiting
60 participants
Started: Jan 10, 2023 · Completed: Jul 1, 2025
1 condition
1 sponsor
1 location
NCT05689112
Microscopy Imaging of Whole-mount Stained Human Tissues
N/A
Recruiting
250 participants
Started: Jan 10, 2023 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05990686
Paracetamol Plus Tramadol Versus Fentanyl in Day Case Surgeries
N/A
Recruiting
132 participants
Started: Jan 10, 2023 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT05638113
Prolonged Air Leakage After Major Lung Resection
NA
Recruiting
182 participants
Started: Jan 10, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05664945
Rethinking Pulmonary Rehabilitation - a Three-arm Randomised Multicentre Trial
NA
Recruiting
180 participants
Started: Jan 10, 2023 · Completed: Jul 31, 2026
1 condition
4 sponsors
7 locations
NCT05482711
The Fuel and Rhythm (FAR) Phase 2 Study
NA
Recruiting
15 participants
Started: Jan 10, 2023 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT05554302
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
PHASE2
Recruiting
20 participants
Started: Jan 10, 2023 · Completed: Jan 31, 2030
2 conditions
2 sponsors
1 location
NCT04216927
NO During CPB in Neonates to Reduce Risk of AKI
PHASE3
Recruiting
40 participants
Started: Jan 10, 2023 · Completed: Jun 30, 2026
3 conditions
3 sponsors
1 location
NCT04945213
Biperiden Trial for Epilepsy Prevention
PHASE3
Recruiting
312 participants
Started: Jan 10, 2023 · Completed: Dec 20, 2026
3 conditions
11 sponsors
10 locations
NCT05519189
Evaluation of the Value of Perianal Infiltration During Thermodestruction of Haemorrhoidal Disease by Radiofrequency
PHASE4
Recruiting
134 participants
Started: Jan 10, 2023 · Completed: Feb 28, 2026
1 condition
1 sponsor
3 locations
NCT05657197
The Effect of Intensive Physical Exercise on Fatigue and Quality of Life in Patients With Quiescent Inflammatory Bowel Disease
NA
Recruiting
100 participants
Started: Jan 10, 2023 · Completed: Dec 31, 2025
1 condition
5 sponsors
3 locations
NCT03760575
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
PHASE1
Recruiting
20 participants
Started: Jan 10, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05567133
Risk Indicators of Sarcoidosis Evolution-Unified Protocol
N/A
Recruiting
200 participants
Started: Jan 10, 2023 · Completed: Mar 30, 2026
1 condition
4 sponsors
2 locations
NCT05758493
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
PHASE2
Recruiting
150 participants
Started: Jan 10, 2023 · Completed: Mar 10, 2028
2 conditions
2 sponsors
1 location
NCT05158894
Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
N/A
Recruiting
1,884 participants
Started: Jan 10, 2023 · Completed: Sep 30, 2034
1 condition
1 sponsor
1 location
Previous
1
More pages
881
882
883
884
885
886
887
More pages
1333
Next